A New Dawn for Pre-Hospital Heparin in STEMI? Insights From the HEPARIN STEMI Trial

Diana A. Gorog; Antonio Landi

doi:10.1161/circulationaha.126.080190

A New Dawn for Pre-Hospital Heparin in STEMI? Insights From the HEPARIN STEMI Trial

D Diana A. Gorog (National Heart and Lung Institute, Imperial College, London, United Kingdom (D.A.G.).) A Antonio Landi (Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland (A.L.).)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 153, Issue 20

Published May 19, 2026

Pages 1535-1538

DOI 10.1161/circulationaha.126.080190

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (2)

D

Diana A. Gorog

National Heart and Lung Institute, Imperial College, London, United Kingdom (D.A.G.).

A

Antonio Landi

Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland (A.L.).

A New Dawn for Pre-Hospital Heparin in STEMI? Insights From the HEPARIN STEMI Trial

Article Details

Journal Info

Authors (2)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”